Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2026-02-25 @ 9:49 PM
Study NCT ID:
NCT02389751
Status:
COMPLETED
Last Update Posted:
2019-07-24
First Post:
2015-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gastroesophageal Junction Adenocarcinoma | View |
| None | Malignant Neoplasm of the Cervical Esophagus | View |
| None | Malignant Neoplasm of the Thoracic Esophagus | View |
| None | Stage IIA Esophageal Cancer AJCC v7 | View |
| None | Stage IIB Esophageal Cancer AJCC v7 | View |
| None | Stage IIIA Esophageal Cancer AJCC v7 | View |
| None | Stage IIIB Esophageal Cancer AJCC v7 | View |
| None | Stage IIIC Esophageal Cancer AJCC v7 | View |
Keywords: